Literature DB >> 23345583

Seropositivity rates for measles, mumps, and rubella IgG and costs associated with testing and revaccination.

Brian H Shirts1, Ryan J Welch, Marc Roger Couturier.   

Abstract

Retrospective analysis of IgG test results and patterns for measles, mumps, and rubella revealed generally high seropositivity rates, with that of mumps being the lowest. A simplified cost analysis shows that when there is a suspicion of nonimmunity, serological testing may be cheaper than vaccination.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23345583      PMCID： PMC3592343          DOI： 10.1128/CVI.00503-12

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  9 in total

1.  Mumps--United States, 1985-1986.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1987-03-20       Impact factor: 17.586

2.  Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: 
Journal:  MMWR Recomm Rep       Date:  2011-11-25

3.  Recent resurgence of mumps in the United States.

Authors:  Gustavo H Dayan; M Patricia Quinlisk; Amy A Parker; Albert E Barskey; Meghan L Harris; Jennifer M Hill Schwartz; Kae Hunt; Carol G Finley; Dennis P Leschinsky; Anne L O'Keefe; Joshua Clayton; Lon K Kightlinger; Eden G Dietle; Jeffrey Berg; Cynthia L Kenyon; Susan T Goldstein; Shannon K Stokley; Susan B Redd; Paul A Rota; Jennifer Rota; Daoling Bi; Sandra W Roush; Carolyn B Bridges; Tammy A Santibanez; Umesh Parashar; William J Bellini; Jane F Seward
Journal:  N Engl J Med       Date:  2008-04-10       Impact factor: 91.245

4.  Persistence of rubella antibodies after 2 doses of measles-mumps-rubella vaccine.

Authors:  Charles W LeBaron; Bagher Forghani; Lukas Matter; Susan E Reef; Carol Beck; Daoling Bi; Cynthia Cossen; Bradley J Sullivan
Journal:  J Infect Dis       Date:  2009-09-15       Impact factor: 5.226

5.  Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up.

Authors:  Irja Davidkin; Sari Jokinen; Mia Broman; Pauli Leinikki; Heikki Peltola
Journal:  J Infect Dis       Date:  2008-04-01       Impact factor: 5.226

6.  Persistence of mumps antibodies after 2 doses of measles-mumps-rubella vaccine.

Authors:  Charles W LeBaron; Bagher Forghani; Carol Beck; Cedric Brown; Daoling Bi; Cynthia Cossen; Bradley J Sullivan
Journal:  J Infect Dis       Date:  2009-02-15       Impact factor: 5.226

7.  Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  J C Watson; S C Hadler; C A Dykewicz; S Reef; L Phillips
Journal:  MMWR Recomm Rep       Date:  1998-05-22

Review 8.  Measles, mumps, and rubella in Finland: 25 years of a nationwide elimination programme.

Authors:  Heikki Peltola; Sari Jokinen; Mikko Paunio; Tapani Hovi; Irja Davidkin
Journal:  Lancet Infect Dis       Date:  2008-12       Impact factor: 25.071

9.  Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population.

Authors:  Anand A Date; Moe H Kyaw; Alison M Rue; Julie Klahn; Leann Obrecht; Terry Krohn; Josh Rowland; Steve Rubin; Thomas J Safranek; William J Bellini; Gustavo H Dayan
Journal:  J Infect Dis       Date:  2008-06-15       Impact factor: 7.759
  9 in total
  4 in total

1.  Performance Characteristics of a Multiplex Flow Immunoassay for Detection of IgG-Class Antibodies to Measles, Mumps, Rubella, and Varicella-Zoster Viruses in Presumptively Immune Health Care Workers.

Authors:  Elitza S Theel; Marisa Sorenson; Crystal Rahman; Dane Granger; Andrew Vaughn; Laura Breeher
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

2.  Pre-vaccination IgG screening for mumps is the most cost-effectiveness immunization strategy among Health Care Workers.

Authors:  Luca Coppeta; Ottavia Balbi; Savino Baldi; Antonio Pietroiusti; Andrea Magrini
Journal:  Hum Vaccin Immunother       Date:  2019-03-27       Impact factor: 3.452

3.  Prevalence of Inadequate Immunity to Measles, Mumps, Rubella, and Varicella in MLB and NBA Athletes.

Authors:  Justin J Conway; Brett G Toresdahl; Daphne I Ling; Nicole T Boniquit; Lisa R Callahan; James J Kinderknecht
Journal:  Sports Health       Date:  2018-05-24       Impact factor: 3.843

4.  Evaluation of Immunity for Mumps among Vaccinated Medical Students.

Authors:  Cristiana Ferrari; Marco Trabucco Aurilio; Andrea Mazza; Antonio Pietroiusti; Andrea Magrini; Ottavia Balbi; Matteo Bolcato; Luca Coppeta
Journal:  Vaccines (Basel)       Date:  2021-06-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.